<p>I interview Drew McGregor, Vice President, Head of Medical Affairs Excellence & Sustainability at Bayer. </p>
<p><br></p>
<p>We discuss:</p>
<ul>
<li>How to balance patient focus with commercial objectives</li>
<li>How to reduce silos across the organisation </li>
<li>What would pharma look like without a separate MA strategy?</li>
</ul>